Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a consumer health company focused on everyday health products, covers the month of June 2026. The report specifically details transactions in the company's own shares under its share buyback programme announced on March 12, 2026.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 565,285 ordinary shares for cancellation.
- Purchase Date: June 8, 2026.
- Price Range: Highest price paid was 335.00 pence; lowest was 330.50 pence.
- Volume Weighted Average Price: 331.9552 pence per share.
- Registered Share Capital: 8,842,187,061 ordinary shares of £0.01 each.
- Treasury Shares: 12,025,084 shares held as treasury shares.
- Voting Shares: 8,830,161,977 ordinary shares with voting rights.
Material Changes
Following the settlement of the June 8 transaction, the number of ordinary shares with voting rights decreased to 8,830,161,977. No other material financial changes or operational updates are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share buyback transaction.
Investor Verification Checklist
- Verify the total number of shares repurchased under the March 2026 programme to date.
- Confirm the remaining authorization limit for the current share buyback programme.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check the company's website for updated capital structure details post-settlement.